CHI Advisors as of March 31, 2020
Portfolio Holdings for CHI Advisors
CHI Advisors holds 13 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Orchard Therapeutics Plc ads | 52.6 | $22M | 3.0M | 7.53 | |
| Precision Biosciences Ord | 13.4 | $5.7M | 941k | 6.03 | |
| Livongo Health | 6.1 | $2.6M | 90k | 28.53 | |
| Ovid Therapeutics (OVID) | 5.8 | $2.5M | 828k | 2.98 | |
| Blueprint Medicines (BPMC) | 5.0 | $2.1M | 36k | 58.47 | |
| Kezar Life Sciences | 4.7 | $2.0M | 459k | 4.36 | |
| Ultragenyx Pharmaceutical (RARE) | 4.1 | $1.7M | 39k | 44.43 | |
| Global Blood Therapeutics In | 1.9 | $805k | 16k | 51.11 | |
| Corvus Pharmaceuticals (CRVS) | 1.8 | $768k | 364k | 2.11 | |
| Myokardia | 1.7 | $703k | 15k | 46.87 | |
| Adverum Biotechnologies | 1.5 | $623k | 64k | 9.77 | |
| Unum Therapeutics Ord | 0.9 | $389k | 941k | 0.41 | |
| Bluebird Bio | 0.7 | $276k | 6.0k | 46.00 |
